| INSPIRE MEDICAL SYSTEMS |
| USA |
| Gesundheit |
| US4577301090 / A2JLEP |
| 2DR (Frankfurt) / INSP (NYSE) |
| FRA:2DR, ETR:2DR, 2DR:GR, NYSE:INSP |
| - |
| https://www.inspiresleep... |
|
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neur..
>Volltext.. |
| 1046.8 Mio. EUR |
| 825.83 Mio. EUR |
| 804.15 Mio. EUR |
| 59.17 Mio. EUR |
| 115.22 Mio. EUR |
| 3.98 EUR |
| 25.96 Mio. EUR |
| 86.92 Mio. EUR |
| 119.96 Mio. EUR |
| 3.17 |
| 2.01% |
| 84.63% |
| - |
| - |
| - |
| - |
| INSPIRE MEDICAL |
| 24.06.26 |
|